Approval Committee under SEZ Act constituted, defining ex officio membership and developer invitee for pharmaceuticals zone oversight and regulatory coordination. The notification constitutes an Approval Committee under sub section (1) of Section 13 of the Special Economic Zones Act to oversee a pharmaceuticals Special Economic Zone, specifying that the Development Commissioner is Chairperson ex officio, listing interdepartmental ex officio members from commerce, foreign trade, customs/central excise, income tax, banking and state industry bodies, and naming the developer's representative as a special invitee for approval and regulatory coordination under the Act.